Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory bench study on cultured cells without human clinical participants.
PubMed 12937682 · doi:10.1023/a:1025493705728
What was done
Epithalon peptide was added to telomerase-negative human fetal fibroblast cultures to observe its effects on telomerase subunit expression, enzymatic activity, and telomere length.
What was found
The authors reported that Epithalon treatment induced expression of the catalytic subunit of telomerase, stimulated telomerase enzymatic activity, and promoted telomere elongation. The abstract provides no quantitative measurements, sample sizes, concentrations, or statistical values.
Why it matters
The study suggests a possible mechanism for telomerase reactivation in somatic cells by a short synthetic peptide in a laboratory model.
Limits
This is an in vitro study limited to human fetal fibroblast cell cultures, preventing direct extrapolation to adult human physiology or organismal life span. The abstract lacks essential methodological and quantitative details, including control conditions, dosage, sample size, and statistical significance.
Cited by
- supports Epithalon works by enhancing telomerase activity to lengthen or protect cellular telomeres.
- supports Telomerase is an enzyme that helps repair telomeres, and the peptide Epithalon encourages telomerase activity.